Literature DB >> 10082394

Genomic and phylogenetic characterization of coxsackievirus B2 prototype strain Ohio-1.

C Polacek1, A Lundgren, A Andersson, A M Lindberg.   

Abstract

The human picornavirus coxsackievirus B2 (CVB2) is often linked to several infections, from mild respiratory diseases to more severe illnesses such as myocarditis. In this study, we report the complete genome sequence of CVB2 prototype strain Ohio-1. The genome sequence was determined from reverse transcribed viral RNA, amplified with long distance PCR and used for non-radioactive sequencing. The full length PCR amplicons were used for in vitro transcription and the obtained cRNA was lipofected onto green monkey kidney cells, in order to confirm that the PCR generated sequence reflects a viable virus RNA. The CVB2 genome sequence shows a typical enterovirus genome organization with a total length of 7411 nucleotides. Phylogenetic analysis, using the CVB2 polyprotein in comparison with other enterovirus polyproteins, clearly shows that CVB2 clusters with the coxsackievirus B-like enteroviruses and is more related to coxsackievirus B4 (CVB4) than any other published CVB serotype. The grouping of CVB2 and CVB4 as one subgroup has earlier been reported in connection with receptor usage and ability to replicate in different cell lines. The exposed viral capsid proteins of CVB2 (VP1-VP3) show high similarity to other CVB proteins, except in regions that are likely to be surface epitopes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082394     DOI: 10.1016/s0168-1702(98)00140-3

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  4 in total

1.  A single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells.

Authors:  Maria Gullberg; Conny Tolf; Nina Jonsson; Charlotta Polacek; Jana Precechtelova; Miriam Badurova; Martin Sojka; Camilla Mohlin; Stina Israelsson; Kjell Johansson; Shubhada Bopegamage; Susan Hafenstein; A Michael Lindberg
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

2.  5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart.

Authors:  Nora M Chapman; Kyung-Soo Kim; Kristen M Drescher; Kuniyuki Oka; Steven Tracy
Journal:  Virology       Date:  2008-04-01       Impact factor: 3.616

3.  Study of Coxsackie B viruses interactions with Coxsackie Adenovirus receptor and Decay-Accelerating Factor using Human CaCo-2 cell line.

Authors:  Samira Riabi; Rafik Harrath; Imed Gaaloul; Lamjed Bouslama; Dorsaf Nasri; Mahjoub Aouni; Sylvie Pillet; Bruno Pozzetto
Journal:  J Biomed Sci       Date:  2014-05-21       Impact factor: 8.410

4.  Pathogenesis of coxsackievirus B2 in mice: characterization of clinical isolates of the coxsackievirus B2 from patients with myocarditis and aseptic meningitis in Korea.

Authors:  Jiyoung Hong; Bunghak Kang; Sanggu Yeo; Youngmee Jee; Jae-Hak Park
Journal:  J Vet Sci       Date:  2017-12-31       Impact factor: 1.672

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.